Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Revenue

Teva Pharmaceutical had revenue of $3.98B in the quarter ending March 31, 2026, with 2.34% growth. This brings the company's revenue in the last twelve months to $17.35B, up 4.41% year-over-year. In the year 2025, Teva Pharmaceutical had annual revenue of $17.26B with 4.32% growth.

• Revenue (ttm): $17.35B
• Revenue Growth: +4.41%
• P/S Ratio: 2.37
• Revenue / Employee: $511,016
• Employees: 33,950
• Market Cap: 41.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.26B	714.00M	4.32%
Dec 31, 2024	16.54B	698.00M	4.40%
Dec 31, 2023	15.85B	921.00M	6.17%
Dec 31, 2022	14.93B	-953.00M	-6.00%
Dec 31, 2021	15.88B	-781.00M	-4.69%
Dec 31, 2020	16.66B	-228.00M	-1.35%
Dec 31, 2019	16.89B	-1.38B	-7.57%
Dec 31, 2018	18.27B	-3.58B	-16.39%
Dec 31, 2017	21.85B	-50.00M	-0.23%
Dec 31, 2016	21.90B	2.25B	11.45%
Dec 31, 2015	19.65B	-620.00M	-3.06%
Dec 31, 2014	20.27B	-42.00M	-0.21%
Dec 31, 2013	20.31B	-3.00M	-0.01%
Dec 31, 2012	20.32B	2.01B	10.95%
Dec 31, 2011	18.31B	2.19B	13.59%
Dec 31, 2010	16.12B	2.22B	15.99%
Dec 31, 2009	13.90B	2.81B	25.39%
Dec 31, 2008	11.09B	1.68B	17.83%
Dec 31, 2007	9.41B	1.00B	11.89%
Dec 31, 2006	8.41B	3.16B	60.15%
Dec 31, 2005	5.25B	-	-

Data Source: Fiscal.ai Last updated: Apr 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error